Transforming Nanotechnology Into Innovative Therapeutics
Before he died of non-Hodgkin's lymphoma in 2005, Nobel Prize-winning chemist and nanotech pioneer Richard Smalley said, "Twenty years from now, nanoscale missiles will target cancer cells in the human body and leave everything else blissfully alone." That quote provided an introduction to a session at BIO 2012 that examined how nanotechnology had evolved since Smalley's statement more than a decade ago.
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter